The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors
Markian M. Stec(Amgen (United States)), Mark H. Norman(Amgen (United States)), Raju Subramanian(Gilead Sciences (United States)), Nancy R. Zhang(University of the Arts), Leeanne Zalameda(Amgen (United States)), Tisha San Miguel(Amgen (United States)), Douglas A. Whittington(Amgen (United States)), Erin L. Mullady(Amgen (United States)), Ling Wang(Guizhou University), Hongyu Liao, Paul E. Hughes(Amgen (United States)), Tian Wu(Guangzhou University of Chinese Medicine), Sean Caenepeel(Amgen (United States)), Kristin L. Andrews(Amgen (United States)), John D. McCarter(Amgen (United States)), Yunxin Bo(Amgen (United States)), Nuria Tamayo(Amgen (United States))
Cited by 21
Related Papers
Integrin activation controls metastasis in human breast cancer
|Proceedings of the National Academy of Sciences|2001|580
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325